Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry
- Status
- RECRUITING
- Phase
- N/A
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity
- Status
- WITHDRAWN
- Phase
- NA
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL
- Status
- TERMINATED
- Phase
- N/A
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2